Sign in
4

Changes in Ownership

REGENXBIO Inc. Filed Acc 0001562180-19-003604

President and CEO sold 15,000 shares at an average $52.54 ($788,088)

  • President and CEO acquired 15,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Mills Kenneth T. · President and CEO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2019-06-19 Exercise or conversion : show line 1 in the form +15,000 $0.85 $12,750 261,000 D
2019-06-19 Sale : show line 2 in the form −10,880 $52.27 $568,698 250,120 D
2019-06-19 Sale : show line 3 in the form −4,120 $53.25 $219,390 246,000 D
Open-market sales · 15,000 sh · avg $52.54 · $788,088

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-06-19 Exercise or conversion : show line 4 in the form Employee Stock Option (Right to Buy) −15,000 $0.85 2024-09-23 15,000 114,670 D
Loading xslF345X03/primarydocument.xml…